Somaxon Sues Actavis Over Generic Silenor
Somaxon Pharmaceuticals Inc. hit Actavis Inc. with a patent infringement suit in Delaware on Monday over Actavis' bid for regulatory approval to market a generic version of Somaxon's insomnia drug Silenor....To view the full article, register now.
Already a subscriber? Click here to view full article